Patients with NT1 typically show cataplexy and a dramatic reduction in the cerebrospinal fluid concentration of the neuropeptide orexin A (hypocretin 1), which results from extensive loss of the orexin-producing neurons in the hypothalamus (2). The gene discussed is HCRT; the disease is Cataplexy.